Resentment for a person does not usually appear at once, rather, it grows over time; Jeffrey Meltzer helps recognise the early signs.

September 30, 2026, surpassing full trial enrollment targetCompany reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major ...

Citing additional analyses of its ATTAIN-1 Phase 3 trial, Eli Lilly (LLY) on Thursday announced that its oral obesity therapy Foundayo at 17.2 mg was linked to an estimated 57% reduction in risk of ...

If approved, MOGENRY® would be the first disease-agnostic treatment for patients with inherited retinal dystrophies (IRDs) ...

Moderna stock rallied by triple digits when positive news rolled in for its cancer vaccine. But is mRNA ready to return to ...

If you are searching for drug and alcohol rehab in New Jersey that goes beyond detox, you want a program that supports you ...

Dr. Chung asks what operational changes practices should prioritize to prepare for an expanding hepatitis B treatment ...

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently develop improved antibody drug ...

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62 nd EASD ...

There is this weird phenomenon happening on TikTok where people are encouraged to do no work in a relationship and yet expect ...

Lady A singer Charles Kelley has opened up that he has been diagnosed with multiple myeloma, a type of blood cancer that ...

Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for potential accelerated approval based on AATD biomarkers ...